4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001951238-25-000005
Chief Business Officer sold 166,380 shares at an average $8.87 ($1,476,147)
- Chief Business Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chakma Justin Chief Business Officer | 2025-11-12 | Option exercise | +30,000 | $0.84 | $25,200 | 166,380 | D |
| Chakma Justin Chief Business Officer | 2025-11-12 | Sale | −30,000 | $8.91 | $267,357 | 136,380 | D |
| Chakma Justin Chief Business Officer | 2025-11-12 | Sale | −136,380 | $8.86 | $1,208,790 | 0 | D |
| Derivatives | |||||||
| Chakma Justin Chief Business Officer | 2025-11-12 | Option exercise · Stock Option (Right to Buy) | −30,000 | 89,047 | D | ||
| Open-market sales · 166,380 sh · avg $8.87 · $1,476,147 | |||||||
Loading xslF345X05/form4-11142025_111150.xml…